The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I clinical trial of NEO-201, an anti-tumor-associated CEACAM-5/6 monoclonal antibody in solid tumors.
 
Christopher Browning Cole
No Relationships to Disclose
 
Maria Pia Morelli
No Relationships to Disclose
 
Massimo Fantini
Employment - Precision Biologics
 
Maria Fergusson
No Relationships to Disclose
 
Sharon A. Mavroukakis
No Relationships to Disclose
 
Anjum Zaki
Employment - Precision BioLogic
 
Kwong Y. Tsang
Employment - Precision BioLogic
Stock and Other Ownership Interests - Precision Biopsy
 
Philip Martin Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
 
Christina M. Annunziata
Research Funding - Astex Pharmaceuticals (Inst); MaxCyte (Inst); Precision Biologics (Inst)
Patents, Royalties, Other Intellectual Property - MaxCyte (Inst); Precision Biologics (Inst)